L'Air Liquide S.A. (AI.PA) Bundle
From its founding in Paris in 1902 after Georges Claude and Paul Delorme developed a process to liquefy and separate air, L'Air Liquide S.A. has grown through landmark moves-buying Airco in 1985, surpassing €10 billion in revenue by 2004, acquiring Airgas in 2016, investing €1 billion in large electrolyzers in 2021 for low‑carbon hydrogen and agreeing in August 2025 to acquire DIG Airgas for €2.85 billion-to become a public company listed as AI on Euronext with a market capitalization of about €91.53 billion (Dec. 2025), a workforce of roughly 67,800 across 60-70 countries, diversified ownership that includes BlackRock, Vanguard and a minority stake held by the French state, and a business model built on three segments-Gas & Services (the largest, generating €26.36 billion in 2023), Engineering & Construction, and Global Markets & Technologies-while pursuing sustainability targets such as a 30% emissions reduction by 2025 and committing to invest around €8 billion in the low‑carbon hydrogen value chain by 2035 as part of its ADVANCE plan to lift operating margin by 460 basis points by end‑2026.
L'Air Liquide S.A. (AI.PA): Intro
L'Air Liquide S.A. (AI.PA) is a global leader in gases, technologies and services for industry and health. Founded on breakthrough cryogenic air‑separation technology, the company has grown via organic expansion, targeted acquisitions and investments in low‑carbon technologies to serve industrial, healthcare and energy transition markets worldwide.- Headquarters: Paris, France
- Primary activities: Industrial gases, Medical gases & services, Electronics materials, Hydrogen & energy transition solutions
- Global footprint: Operations in 80+ countries
- Employees (approx.): 67,000
- 1902 - Founding: Georges Claude and Paul Delorme developed a practical process for liquefying and separating air, leading to the creation of L'Air Liquide in Paris.
- 1985 - North America expansion: Acquired U.S. industrial gas company Airco, significantly increasing North American market presence.
- 2004 - Revenue milestone: Group surpassed €10 billion in annual revenue, marking its emergence as a global industrial gas powerhouse.
- 2016 - Airgas acquisition: Completed acquisition of Airgas (U.S. distributor), enhancing distribution channels and customer reach in North America (deal value approximately $13.4 billion).
- 2021 - Low‑carbon hydrogen investment: Announced a €1 billion investment in two large electrolyzers in the Netherlands to produce low‑carbon hydrogen as part of the energy transition.
- August 2025 - Asia expansion: Agreed to acquire South Korea's DIG Airgas for €2.85 billion, expanding presence in the Asian market.
- Production: Large-scale air separation units (ASUs), cryogenic liquefaction, reforming and electrolysis for hydrogen; specialized gas generation at point-of-use.
- Distribution: Bulk deliveries (liquid and gas), packaged gas cylinders, pipeline networks and on-site gas production for large industrial customers.
- Services & technology: Engineering, installation, maintenance, gas management services, and digital monitoring for uptime and efficiency.
- Market segmentation: Industrial manufacturing (metals, chemicals, refining), healthcare (medical oxygen & services), electronics (ultra‑pure gases), energy & environment (hydrogen, CO2 management).
- Product sales: Long‑term contracts for bulk and packaged gases provide recurring revenue and predictable cash flows.
- On‑site & pipeline contracts: Capital‑intensive, higher-margin on‑site production and pipeline supply agreements under long-duration contracts.
- Value‑added services: Engineering, maintenance, gas management and specialty applications increase customer stickiness and margin.
- Technology & IP: Proprietary separation, liquefaction, electrolyzer integration and purification technologies support premium pricing in key segments (electronics, healthcare, hydrogen).
| Item | Figure / Note |
|---|---|
| Founding year | 1902 |
| 2004 annual revenue milestone | Surpassed €10 billion |
| 2016 strategic acquisition | Airgas (U.S.) - deal ≈ $13.4 billion |
| 2021 hydrogen investment | €1 billion for two electrolyzers in the Netherlands |
| 2025 strategic acquisition | Agreed purchase of DIG Airgas (South Korea) - €2.85 billion |
| Employees (approx.) | 67,000 |
| Geographic reach | Operations in 80+ countries |
- Scale & integration: Leverage global industrial gas assets and distribution to defend market share and capture cross‑sell.
- Energy transition: Invest in low‑carbon hydrogen, electrolyzers, CCUS and renewables-linked hydrogen ecosystems.
- Digitalization & services: Expand predictive maintenance, remote monitoring and gas management platforms to improve margins.
- Selective M&A: Use acquisitions (e.g., Airgas, DIG Airgas) to accelerate geographic growth and bolster distribution networks.
L'Air Liquide S.A. (AI.PA): History
L'Air Liquide S.A., founded in 1902 in France, grew from a small oxygen supplier into a global leader in industrial gases and related services. Over the 20th and 21st centuries the group expanded through technological innovation, international expansion and targeted acquisitions, diversifying into healthcare gases, specialty gases, and hydrogen energy solutions. Key historical milestones include early oxygen production for industry, post‑war internationalization, the creation of a healthcare division, and recent strategic pivots toward low‑carbon hydrogen and digital services.- Founded: 1902 (France)
- Core businesses developed: Industrial gases, Healthcare, Electronics gases, Hydrogen & Engineering
- Global footprint: Operations in 80+ countries
| Metric | Value |
|---|---|
| Ticker / Exchange | AI - Euronext Paris |
| Market Capitalization (Dec 2025) | €91.53 billion |
| Revenue (latest reported year) | €23.9 billion (approx.) |
| Employees (approx.) | ~67,000 |
| Headquarters | Paris, France |
- Publicly listed company with widely held free float
- Large institutional shareholders include BlackRock and The Vanguard Group
- French State Investment Agency (APE) holds a minority stake, reflecting strategic public interest
- Numerous individual and retail shareholders contribute to a diversified ownership base
- Mission: Provide gases, technologies and services for industry, healthcare and the environment while progressing toward carbon neutrality
- Strategic priorities: Low‑carbon hydrogen, carbon capture & storage, healthcare expansion, digitalization of services
- Core revenue drivers:
- Sale of industrial, medical and specialty gases (bulk and packaged)
- On‑site gas production and long‑term supply contracts (air separation units, ASUs)
- Engineering, installation and maintenance services for gas facilities
- Healthcare services and medical gases supplied to hospitals and clinics
- Emerging revenue from hydrogen production, distribution and mobility solutions
- Business model features: High recurring revenue from long‑term contracts, capital‑intensive assets with stable margins, and diversification across end markets (chemicals, energy, electronics, healthcare).
| Shareholder | Type |
|---|---|
| BlackRock | Institutional investor |
| The Vanguard Group | Institutional investor |
| French State Investment Agency (APE) | Government minority stake |
| Retail & Other Institutional Investors | Diverse public float |
L'Air Liquide S.A. (AI.PA): Ownership Structure
L'Air Liquide S.A. (AI.PA) is a global leader in industrial and medical gases, combining a long corporate history with an explicit mission to support industry and healthcare through gases, technologies and services.- Mission: Provide innovative gases, technologies and services that contribute to human progress by supporting industry and healthcare.
- Sustainability target: reduce carbon emissions by 30% by 2025 (scope 1 & 2 intensity and across key processes as declared by the company).
- Innovation focus: hydrogen energy, carbon capture, industrial electrification and digital solutions for plant optimization.
- Safety: strict HSE protocols, process safety programs and continuous training to protect employees, customers and communities.
- Integrity & ethics: compliance programs, transparent reporting and strong governance standards.
- Diversity & inclusion: global initiatives to increase representation and equal opportunity across regions and functions.
- Core businesses: Industrial gases (oxygen, nitrogen, argon), medical gases & healthcare services, and engineering/technology for gas production and handling.
- Revenue streams: long-term supply contracts, on-site production (air separation units, ASUs), cylinder & packaged gases, and service/maintenance agreements.
- Growth drivers: hydrogen mobility & refueling infrastructures, large-scale industrial decarbonization projects, and bundled digital services for industrial customers.
| Metric | Figure (most recent reported) |
|---|---|
| Annual revenue | €23.6 billion |
| Net income (group share) | €2.8 billion |
| Market capitalization (approx.) | ~€60 billion |
| Employees | ~67,000 |
| 2025 carbon intensity reduction target | -30% |
| Dividend per share (latest) | €2.90 |
L'Air Liquide S.A. (AI.PA): Mission and Values
L'Air Liquide S.A. (AI.PA) is a global leader in gases, technologies and services for industry and health. Founded in 1902 and publicly listed in Paris, the group combines large-scale supply infrastructure with engineering capabilities and market-facing innovation to serve diverse sectors from metallurgy and chemicals to healthcare and electronics. How it works- Three operating segments:
- Gas & Services - production, supply, and on-site management of industrial gases (oxygen, nitrogen, hydrogen, argon, specialty gases) to industrial customers and hospitals.
- Engineering & Construction - design, build and commission of air separation units, hydrogen trains, cryogenic equipment and turnkey industrial gas production installations.
- Global Markets & Technologies - development and commercialization of advanced technologies and solutions for healthcare, electronics, new energies (notably hydrogen), and specialty applications.
- Supply chain and assets - a diversified mix of large air separation plants, on-site production units at customer sites, merchant supply networks (cylinders, bulk tanks), and cryogenic logistics enabling continuous, reliable deliveries.
- R&D and innovation - sustained investment in research to improve process efficiency, low-carbon hydrogen production, gas applications for electronics and healthcare technologies.
- Global footprint and workforce - approximately 67,800 employees across 60 countries providing local operations backed by centralized technical and commercial capabilities.
| Metric (approx.) | Value |
|---|---|
| Group revenue (2023) | €23.5 billion |
| Gas & Services revenue (share) | €18.8 billion (~80%) |
| Engineering & Construction revenue (share) | €2.7 billion (~11%) |
| Global Markets & Technologies revenue (share) | €2.0 billion (~9%) |
| Employees | ~67,800 (60 countries) |
| R&D spend (annual, approx.) | €328 million |
| Recurring operating income (EBITA, approx.) | €4.1 billion |
- Gas & Services:
- Sale of commodity gases by volume (bulk, cylinders, on-site production) - recurring revenue, long-term contracts with industrial clients (metals, chemicals, refining, food & beverage).
- On-site contracts and services - CAPEX-backed on-site plants providing predictable margins and multi-year revenue streams.
- Value-added services - gas management, safety services, maintenance and optimization.
- Engineering & Construction:
- Project delivery fees for designing and building air separation units, hydrogen facilities and cryogenic systems.
- Turnkey engineering projects for third parties and internal investment in customer plants that later generate Gas & Services revenues.
- Global Markets & Technologies:
- High-margin specialty gases and technologies for electronics, life sciences and healthcare.
- New energy solutions (low-carbon hydrogen production, hydrogen refueling stations) - growing commercial contracts, infrastructure deployment and technology licensing.
- Customer mix - heavy industry (metals, chemicals, refining), healthcare (medical oxygen and technologies), electronics (ultra-pure gases), and energy (hydrogen for mobility and decarbonization).
- Asset mix - merchant distribution vs. on-site production; on-site plants typically generate higher margin and more stable cash flows.
- Hydrogen focus - investment in low-carbon hydrogen production (electrolysis, CCS-enabled hydrogen) and hydrogen mobility infrastructure; hundreds of hydrogen refueling stations and multiple large-scale industrial hydrogen projects under development.
- Capital intensity - significant CAPEX for plant construction and logistics; balanced by long-term contracts and predictable consumption profiles of industrial customers.
- Recurring, volume-driven revenue from long-term industrial contracts underpins operating cash flow.
- Engineering & Construction drives cyclical project revenue and can be a lever for strategic gains (selling plants or capturing industrial projects).
- Investments in hydrogen and specialty markets aim to increase higher-margin and growth-oriented revenue streams over the medium term.
- Energy transition - focus on decarbonizing production (electrification of air separation, low-carbon hydrogen routes) to meet corporate targets and capture demand from decarbonizing industries.
- Healthcare and electronics - advanced gas solutions and technologies that command premium pricing and recurring service revenue.
- R&D pipeline - continuous development of efficiency improvements, new gas applications, and technologies supporting circular economy and lower lifecycle emissions.
L'Air Liquide S.A. (AI.PA): How It Works
L'Air Liquide S.A. (AI.PA) is built around the industrial-gas value chain: production, distribution, on-site supply and associated services for industries such as healthcare, chemicals, energy, electronics, metallurgy and food. Revenues flow from commodity and specialty gases, long-term supply contracts, engineering design and construction of production units, and technology & services tied to higher-margin applications (medical, electronics, hydrogen, CO2 capture).- Primary revenue driver: sale of industrial gases (oxygen, nitrogen, argon, hydrogen, specialty gas mixtures) and associated on-site services.
- Recurring, contract-linked cash flows from long-term supply agreements (industrial sites, hospitals, electronics fabs).
- Engineering & Construction (E&C) income from turnkey builds and modular production units under multi-year contracts.
- Global Markets & Technologies revenues from healthcare solutions, electronics process gases, and emerging energy technologies (notably hydrogen).
- Investment income and JV/partnership returns (e.g., low-carbon oxygen projects with major energy players).
| Segment | 2023 Revenue (EUR) | Year-on-Year Change |
|---|---|---|
| Gas & Services | €26.36 billion | +4.2% |
| Engineering & Construction | €3.55 billion (approx.) | variable; project-timed |
| Global Markets & Technologies | €1.02 billion (approx.) | growth in healthcare & electronics |
| JVs / Partnerships (selected projects) | €850 million (example low-carbon O2 project equity & commitments) | strategic, multi-year |
| Total (illustrative) | €30.93 billion (sum of above) | - |
- Gas production & distribution: high-capex assets with steady utilization and scale benefits; margins driven by on-site model vs. bulk delivery.
- Long-term contracts: price indexation and volume commitments reduce volatility and generate predictable free cash flow.
- Engineering & Construction: typically lumpy revenue with lower recurring margin but enables future upstream supply contracts and equipment sales.
- Technology & services: higher-margin, recurring streams from medical devices, specialty gases for semiconductors, and hydrogen mobility/refueling networks.
- JVs & partnerships: share capital returns and access to large-scale decarbonization projects (e.g., low-carbon oxygen in Texas with ExxonMobil - €850m scale participation).
| Lever | Effect on Profitability / Cash |
|---|---|
| Operational efficiency (asset optimization, procurement) | Reduces unit production cost; improves EBITDA margin. |
| Contract mix (on-site vs. merchant) | On-site contracts provide higher gross margin and stability; merchant sales more volume-sensitive. |
| CapEx allocation (industrial gases vs. hydrogen & low-carbon) | Shapes future growth and potential margin uplift from energy-transition projects. |
| Price indexation & pass-through mechanisms | Protects revenues against input-cost inflation (energy, oxygen, logistics). |
- Healthcare: medical gases, homecare inhalation devices, hospital supplies - stable, defensive demand.
- Electronics: ultra-pure gases and specialty delivery systems - high growth, high margin.
- Energy & mobility: hydrogen production, refueling, and low-carbon projects - strategic growth area.
- Metallurgy & chemicals: bulk industrial gases for processes - large volumes, lower margin but scale-stable.
- Investments in hydrogen electrolysis and low-carbon oxygen projects to capture emerging energy transition revenue streams.
- Digitalization and service packages (gas-as-a-service, remote monitoring) to increase recurring revenue and lower service costs.
- Selective M&A and JVs to access regional markets and large industrial partners (e.g., partnerships like the €850 million project with ExxonMobil).
L'Air Liquide S.A. (AI.PA): How It Makes Money
L'Air Liquide S.A. generates revenue primarily by producing and selling industrial gases, related equipment and services, and healthcare products (medical gases, home healthcare). Its business model combines long-term contracts, on-site plants for large industrial customers, packaged gas distribution, and a growing set of energy-transition and service solutions.- Core revenue streams: bulk industrial gases (oxygen, nitrogen, argon, hydrogen), packaged gases and cylinders, on-site operations, and healthcare services.
- Contract types: long-term take-or-pay contracts with large industrial clients; shorter-cycle sales for packaged gases and medical supplies.
- Value-added services: engineering, installation and maintenance of on-site plants, gas management, and emerging low-carbon hydrogen projects.
| Metric | Value / Target |
|---|---|
| Global rank by gas revenue (late 2025) | 2nd (behind Linde plc) |
| Geographic presence | Over 70 countries |
| Customers & patients served | More than 4 million |
| 2024 reported revenue (approx.) | €23.6 billion |
| ADVANCE operating margin improvement target | +460 basis points by end-2026 |
| Planned low-carbon hydrogen investment | ~€8 billion by 2035 |
- Scale and reach: leadership as the second-largest industrial-gas supplier by revenue gives pricing power, broad customer access and diversified end-markets (energy, healthcare, electronics, chemicals, metallurgy).
- ADVANCE plan: operational improvements and portfolio actions designed to lift operating margin by 460 bps through efficiency, pricing, and higher-value services by 2026.
- Energy transition play: committed ~€8 billion to low-carbon hydrogen through 2035 to capture demand from industry decarbonization, mobility and power applications.
- Innovation & sustainability: investments in R&D, electrolyzer partnerships, CCUS and hydrogen logistics position the company to monetize new green-hydrogen value chains.

L'Air Liquide S.A. (AI.PA) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.